Apoptosis, clearance mechanisms, and the development of systemic lupus erythematosus.

被引:34
|
作者
Navratil J.S. [1 ]
Ahearn J.M. [1 ]
机构
[1] University of Pittsburgh School of Medicine, University of Pittsburgh Arthritis Institute, S705 Biomedical Science Tower, 3500 Terrace Street, Pittsburgh, 15261, PA
关键词
Systemic Lupus Erythematosus; Apoptotic Cell; Immune Tolerance; Classical Pathway; Congenital Heart Block;
D O I
10.1007/s11926-001-0018-1
中图分类号
学科分类号
摘要
Cell death by apoptosis is an integral part of many biologic processes, including embryonic development, T- and B-cell selection, the elimination of potentially autoreactive lymphocytes in the periphery, and maintenance of lymphocyte homeostasis through activation-induced cell death. There is also increasing evidence that apoptosis may maintain immune tolerance and that it may be the process that generates the self antigens responsible for the initial development of autoimmunity. This review discusses some of the biochemical steps involved in the apoptotic process, how potentially immunogenic self antigens are generated during apoptosis, and the mechanisms by which the products of apoptosis are cleared and processed to avoid breaking immune tolerance.
引用
收藏
页码:191 / 198
页数:7
相关论文
共 50 条
  • [31] Predictors of Seizures in Systemic Lupus Erythematosus.
    Hanly, John G.
    Urowitz, Murray B.
    Su, Li
    Gordon, Caroline
    Bae, Sang-Cheol
    Sanchez-Guerrero, Jorge
    Romero-Diaz, Juanita
    Wallace, Daniel
    Clarke, Ann E.
    Bernatsky, Sasha
    Ginzler, E. M.
    Merrill, Joan T.
    Isenberg, David A.
    Rahman, Anisur
    Petri, M.
    Fortin, Paul R.
    Gladman, Dafna D.
    Bruce, Ian N.
    Steinsson, Kristjan
    Dooley, M. A.
    Khamashta, Munther A.
    Alarcon, Graciela S.
    Fessler, Barri J.
    Ramsey-Goldman, Rosalind
    Manzi, Susan
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S226 - S227
  • [32] Haptoglobin phenotype in systemic lupus erythematosus.
    Saffari, Y
    Bozorgmehr, J
    Sadrzadeh, SMH
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 122 (03) : 458 - 459
  • [33] Neuropsychological functioning in systemic lupus erythematosus.
    Waller, K
    McGill, JC
    Pertusi, R
    Franks, S
    Harrell, E
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 1999, 14 (01) : 146 - 146
  • [34] Bone infarcts in systemic lupus erythematosus.
    Libes, J
    Petri, M
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S525 - S526
  • [35] Association of malignancy in systemic lupus erythematosus.
    Quintero-Del-Rio, AI
    Feo, LM
    Morrisey, J
    Kim, X
    Harley, JB
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S592 - S592
  • [36] Mycophenolate mofetil for systemic lupus erythematosus.
    Pashinian, N
    Wallace, DJ
    Klinenberg, JR
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S110 - S110
  • [37] Intravenous immunoglobulins in systemic lupus erythematosus.
    Papo, T
    REVUE DE MEDECINE INTERNE, 1999, 20 : 414S - 418S
  • [38] Joint laxity in Systemic Lupus Erythematosus.
    Gumà, M
    Olive, A
    Forcada, J
    Duro, JC
    Roca, J
    Holgado, S
    Casado, E
    Tena, X
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S334 - S334
  • [39] Acquired hemophilia in systemic lupus erythematosus.
    Starke, CR
    Rosen, SA
    Crookston, KP
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 120 (02) : 283 - 283
  • [40] Ethnic variation in systemic lupus erythematosus.
    Johnson, S
    Gladman, DD
    Ibanez, D
    Urowitz, MB
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S694 - S694